Short answer · Medically reviewed summary · Last updated: 2026-05-08
Palmoplantar keratoderma (PPK) is a heterogeneous group of disorders characterized by abnormal thickening of the skin on the palms and soles, with a prevalence that varies significantly by subtype. While some hereditary forms are considered rare or ultra-rare, milder, acquired, or common genetic variants often result in significant underdiagnosis, making exact global prevalence numbers difficult to establish. What is the estimated prevalence and incidence of Palmoplantar Keratoderma? Because Palmoplantar keratoderma encompasses a wide spectrum of conditions—ranging from isolated hereditary keratodermas to those associated with systemic syndromes—there is no single global prevalence figure.
What is the prevalence of Palmoplantar Keratoderma?
Prevalence of Palmoplantar Keratoderma: how many people are affected worldwide, differences by sex and region, with sources.
Palmoplantar keratoderma (PPK) is a heterogeneous group of disorders characterized by abnormal thickening of the skin on the palms and soles, with a prevalence that varies significantly by subtype. While some hereditary forms are considered rare or ultra-rare, milder, acquired, or common genetic variants often result in significant underdiagnosis, making exact global prevalence numbers difficult to establish.
What is the estimated prevalence and incidence of Palmoplantar Keratoderma?
Because Palmoplantar keratoderma encompasses a wide spectrum of conditions—ranging from isolated hereditary keratodermas to those associated with systemic syndromes—there is no single global prevalence figure. According to Orphanet, some specific genetic subtypes of Palmoplantar keratoderma, such as Mal de Meleda, have an estimated prevalence of less than 1 in 100,000. Conversely, common forms like keratoderma climactericum may affect a larger percentage of the aging population. Incidence rates are similarly difficult to track, as many individuals with mild symptoms never seek formal clinical diagnosis.
Does gender, age, or ethnicity affect Palmoplantar Keratoderma?
The clinical presentation of Palmoplantar keratoderma often depends on the specific genetic mutation or acquired cause:
- Gender: Most hereditary forms of Palmoplantar keratoderma show no significant gender bias, though acquired forms (like climacteric keratoderma) are predominantly observed in women.
- Age of Onset: Hereditary Palmoplantar keratoderma typically manifests in infancy or early childhood. Acquired forms can emerge at any stage of adulthood.
- Geographic/Ethnic Variation: Certain subtypes show founder effects, meaning they are more prevalent in specific isolated populations or ethnic groups due to genetic clustering.
Why is accurate data for Palmoplantar Keratoderma limited?
Accurate epidemiological data for Palmoplantar keratoderma is hampered by frequent misdiagnosis, where the condition is mistaken for chronic eczema, psoriasis, or fungal infections. At DiseaseMaps.org, 12 community members have shared their experiences, providing a crucial real-world perspective that highlights how the diagnostic journey for Palmoplantar keratoderma can often take years, leading to significant underreporting in traditional medical databases.
Next steps
- Consult a board-certified dermatologist for a clinical evaluation and potential genetic testing.
- Join the DiseaseMaps.org community to connect with others sharing similar experiences.
- Maintain a detailed symptom diary to assist your physician in differentiating between hereditary and acquired subtypes.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.
References
- Orphanet (Rare Disease Database): https://www.orpha.net/
- NIH Genetic and Rare Diseases (GARD) Information Center: https://rarediseases.info.nih.gov/
- Online Mendelian Inheritance in Man (OMIM): https://www.omim.org/
- DiseaseMaps.org Patient Community Data.
